Latest TB research publications
Economic implications of novel regimens for tuberculosis
treatment in three high-burden countries: a modelling
analysis
The Lancet Global Health
June 2024 /open access/
--
Accompanying comment:
Economic aspects of shortening the duration of
tuberculosis treatment
/open access/
**************
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for
drug-sensitive and drug-resistant pulmonary
tuberculosis treatment: a phase 2c, open-label,
multicentre, partially randomised controlled trial
The Lancet Infectious Diseases
17 May 2024 /open access/
**************
Relationship between HIV viral suppression
and multidrug-resistant tuberculosis
treatment outcomes
PLOS Global Public Health
6 May 2024 /open access/
**************
